Results 31 to 40 of about 51,325 (311)

Dendrimer Conjugation Enhances Tumor Penetration and Cell Kill of Doxorubicin in 3D Coculture Lung Cancer Models [PDF]

open access: yes, 2020
Background: Doxorubicin (DOX) is a potent chemotherapeutic widely used for solid tumors (1). Despite high efficacy in 2D cell culture, DOX efficacy does not translate to in vivo lung cancer models (2).
Almuqbil, Rashed   +5 more
core   +1 more source

Bionanomedicine: A “Panacea” In Medicine? [PDF]

open access: yes, 2017
Recent advances in nanotechnology, biotechnology, bioinformatics, and materials science have prompted novel developments in the field of nanomedicine. Enhancements in the theranostics, computational information, and management of diseases/disorders are ...
Anurogo, D. (Dito)   +2 more
core   +1 more source

Designing hollow nano gold golf balls. [PDF]

open access: yes, 2014
Hollow/porous nanoparticles, including nanocarriers, nanoshells, and mesoporous materials have applications in catalysis, photonics, biosensing, and delivery of theranostic agents.
Anzenberg, Paula   +11 more
core   +1 more source

Folate-conjugated nanoparticles as a potent therapeutic approach in targeted cancer therapy [PDF]

open access: yes, 2015
The selective and efficient drug delivery to tumor cells can remarkably improve different cancer therapeutic approaches. There are several nanoparticles (NPs) which can act as a potent drug carrier for cancer therapy.
Bahrami, B.   +8 more
core   +1 more source

Effect of Paclitaxel Loaded Chitosan Nanoparticles and Quantum Dots on Breast Cancer

open access: yesProceedings, 2017
The aim of the study was to investigate the effect of paclitaxel loaded nanocarrier systems (chitosan nanoparticles or quantum dots) on breast cancer. Paclitaxel loaded chitosan nanoparticles and quantum dots were prepared with the particle size of 153.6
Gülen Melike Demir   +5 more
doaj   +1 more source

Chitosan Based MicroRNA Nanocarriers

open access: yesPharmaceuticals, 2022
Vectorization of microRNAs has shown to be a smart approach for their potential delivery to treat many diseases (i.e., cancer, osteopathy, vascular, and infectious diseases). However, there are barriers to genetic in vivo delivery regarding stability, targeting, specificity, and internalization.
Hussein H. Genedy   +2 more
openaire   +4 more sources

Polyester-Based, Biodegradable Core-Multishell Nanocarriers for the Transport of Hydrophobic Drugs [PDF]

open access: yes, 2016
A water-soluble, core-multishell (CMS) nanocarrier based on a new hyperbranched polyester core building block was synthesized and characterized towards drug transport and degradation of the nanocarrier. The hydrophobic drug dexamethasone was encapsulated
Haag, Rainer   +2 more
core   +4 more sources

Nanocarriers for delivery of siRNA as gene silencing mediator

open access: yesEXCLI Journal : Experimental and Clinical Sciences, 2022
The term nanocarrier refers to sub-micrometric particles of less than 100 nm, designed to transport, distribute, and release nanotechnology-based drug delivery systems. siRNA therapy is a novel strategy that has great utility for a variety of treatments,
Aideé Morales-Becerril   +4 more
doaj   +1 more source

Nasal delivery of neurotherapeutics via nanocarriers: Facets, aspects, and prospects

open access: yesFrontiers in Pharmacology, 2022
Alzheimer’s disease (AD) is one of the neurological ailments which continue to represent a major public health challenge, owing to increased life expectancy and aging population.
Amarjitsing Rajput   +2 more
doaj   +1 more source

Atomic-level characterization and cilostazol affinity of poly(lactic acid) nanoparticles conjugated with differentially charged hydrophilic molecules [PDF]

open access: yes, 2018
Indexación: Scopus.M.F.M. acknowledges support from CONICYT-PFCHA/Doctorado Nacional/2014-21140225. M.M.M. thanks the FONCyT PICT-2015-2191, CONICET PIP 11220110100992, Secyt, Universidad Nacional de Cordoba. C.V.
Ludueña, M.   +4 more
core   +2 more sources

Home - About - Disclaimer - Privacy